Adeia Inc., together with its subsidiaries, operates as a media and semiconductor intellectual property licensing platform company in the United States, Asia, Canada, Europe, the Middle East, and internationally.
FAIL · Does not pass the screen
16.93 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 04:07 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price16.93 USD at the 4 Nov 2026 close
Fair valueUnder review: our model's value is 2.12x the price, above our 2.00x limit.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.51, read 2026-11-02
Ethical does not pass the values gate
Price16.93 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-10-25Read Distribution22.56-25.0% to today ✓Markdown gives way to Distribution after a 12% slide in 2 weeks
2026-10-11Read Markdown25.74-34.2% to today ✓Accumulation gives way to Markdown
2026-10-02Read Accumulation24.81-31.8% to today Distribution gives way to Accumulation with volume flow in agreement
2026-09-19Read Distribution24.90-32.0% to today ✓Markup gives way to Distribution after a 12% slide in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Adeia Inc. holds its Distribution at $16.93. The statistical read favours the sellers, held for 42 days.
As held on the ledger · 2026-11-04
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 42 days
Price at the screen
$16.93
Valuation
16.43 trailing · 12.43 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.01
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
41.16%
Below 33%
Interest-bearing debt is 41.2% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
6.12%
Below 33%
Cash held in interest-bearing accounts and securities is 6.1% of assets, under the one-third limit.
Pass
Receivables
9.79%
Below 49%
Money owed to the company is 9.8% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Adeia's business is in a permissible area, but its interest-bearing debt is about 41% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ADEA's ethical verdict changes
Today ADEA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Our model's value is 2.12x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Patent landlord licensing tech at a bargain price
Picture the quiet owner of the patents inside every smart TV and chip, collecting steady fees while the hardware makers battle it out. Adeia sits in that position, licensing media and semiconductor intellectual property across the globe. The business clears 27 percent profit margins, delivers 29 percent return on equity and is growing revenue at 20 percent, all while trading at 16.4 times forward earnings.
That combination produces a 53 percent margin of safety against our fair value of 38.88, well above the current 25.38 share price and the four-analyst median target of 38. The ethical screen clears cleanly, and the licensing model avoids many of the heavy capital demands that weigh on typical software firms.
Yet the moat remains unproven, leaving room for patent challenges or shifts in licensing norms that could erode collections. Currency moves across its Asian and European markets add another layer of volatility that the numbers do not fully capture.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ADEA trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-02Distribution$21.45+0.0%Entry 19
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Distribution$21.45-5.5%Entry 18
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Distribution$22.70+0.0%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Distribution$22.70+0.0%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Distribution$22.70+0.6%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Distribution$22.56+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Distribution$22.56+0.0%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Distribution$22.56+0.0%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37.
2026-10-18Markdown$21.74-15.5%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 15.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 41% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 124%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (4 analysts) rates it none, with a mean price target of $37.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
